NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: ONMD 72.9%
OneMedNet Stock Soars 90% Following Real-World Data Platform Launch
NASDAQ: BYND 32.83%
Expected US Company Earnings on Wednesday, February 25th, 2026
NASDAQ: VEEA 30.24%
Veea Shares Surge After Launch of TerraFabric Edge Computing Platform
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
OTC: NGNE 77.39%
OTC: KORE 77.39%
OTC: ONMD 77.39%
OTC: BYND 77.39%
OTC: VEEA 77.39%
